Table Of Content

Breast Cancer Research and Treatment ‘°''%7°% Kluwer Boston, USA CONTENTS VOL. 52, NO. 1-3, 1998 Special issue Prognostic variables in node-negative and node-positive breast cancer — Part II Giampietro Gasparini, guest editor Cyclin D1 in breast cancer DM Barnes, CE Gillett Cyclins and breast cancer PS Steeg, Q Zhou Prognostic implications of expression of the cell cycle inhibitor soy" S Cariou, C Catzavelos, JM Slingerland The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer WJ Gullick, R Srinivasan c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients S De Placido, C Carlomagno, M De Laurentiis, AR Bianco HER-2/neu as a predictive marker of response to breast cancer therapy MD Pegram, G Pauletti, DJ Slamon Prognostic and predictive value of p53 and p21 in breast cancer RM Elledge, DC Allred The urokinase plasminogen activator system as a target for prognostic studies in breast cancer RW Stephens, N Briinner, F Janicke, M Schmitt 99-111 Metalloproteinases and tissue inhibitors of metalloproteinases M Toi, S Ishigaki, T Tominaga 113-124 Matrix metalloproteinase inhibitors PD Brown 125-136 The 67 kDa laminin receptor as a prognostic factor in human cancer S Ménard, E Tagliabue, MI Colnaghi 137-145 Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis R Heimann, D Ferguson, S Gray, S Hellman 147-158 Clinical significance of angiogenic factors in breast cancer N Locopo, M Fanelli, G Gasparini 159-173 Insulin-like growth factors in human breast cancer MJ Ellis, S Jenkins, J Hanfelt, ME Redington, M Taylor, R Leek, K Siddle, A Harris 175-184 Molecular prognostic markers in breast cancer R Dahiya, G Deng 185-200 Prognostic significance of micrometastatic bone marrow involvement S Braun, K Pantel 201-216 Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis I Jatoi 217-225 Time-dependence of hazard ratios for prognostic factors in primary breast cancer SG Hilsenbeck, RM Ravdin, CA de Moor, GC Chamness, CK Osborne, GM Clark 227-237 Circulating tumor markers in breast cancer: Accepted utilities and novel prospects V Stearns, H Yamauchi, DF Hayes 239-259 The relationship between prognostic and predictive factors in the management of breast cancer IC Henderson, AJ Patek 261-288 Methodological challenges in the evaluation of prognostic factors in breast cancer DG Altman, GH Lyman 289-303 Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful? DF Hayes, B Trock, AL Harris 305-319 Prognostic variables in node-negative and node-positive breast cancer — editorial G Gasparini 321-331 Author index, Volume 52 J33 Subject index, Volume 52 335-337 Instructions for authors 339-340